Figures & data
Table 1. Innovation attributes related to healthcare.
Baum RA, Baum S. Interventional radiology: a half century of innovation. Radiology. 2014;273(2 Suppl):S75–S91. Joseph ML, Huber DL, Bair H, et al. A typology of innovations in nursing. J Nurs Adm. 2019;49(7–8):389–395. Consoli D, Mina A. An evolutionary perspective on health innovation systems. J Evol Econ. 2009;19(2):297–319. Ellner AL, Stout S, Sullivan EE, et al. Health systems innovation at academic health centers: leading in a new era of health care delivery. Acad Med. 2015;90(7):872–880. Malik NN. Controlling the cost of innovative cancer therapeutics. Nat Rev Clin Oncol. 2009;6(9):550–552. Hamilton BH, Hincapié A, Miller RA, et al. Innovation and diffusion of medical treatment. St. Louis: National Bureau of Economic Research; 2018. Hübner U. What are complex eHealth innovations and how do you measure them? Methods Inf Med. 2015;54(4):319–327. Council NC. NICE Citizens Council Reports. Health innovation and value. London: National Institute for Health and Care Excellence (NICE) Copyright © 2009 National Institute for Health and Clinical Excellence; 2009. McGloughlin EK, Anglim P, Keogh I, et al. Innovation for the future of Irish MedTech industry: retrospective qualitative review of impact of BioInnovate Ireland’s clinical fellows. BMJ Innov. 2018;4(1):32–38. Ferner R, Hughes DA, Aronson J. NICE and new: appraising innovation. BMJ. 2010;340(2):b5493–b5493. Quinn C, Palmer S, Bruns J, et al. Progressive innovation in oncology: valuing outcomes beyond survival. Value in Health. 2015;18(7):A482. Sheard L, Jackson C, Lawton R. How is success achieved by individuals innovating for patient safety and quality in the NHS? BMC Health Serv Res. 2017;17(1):1–9. Mestre-Ferrandiz JM, Sussex J. The many faces of innovation. A report for the ABPI by the Office of Health Economics; 2012. Garrett MD, Workman P. Discovering novel chemotherapeutic drugs for the third millennium. Eur J Cancer. 1999;35(14):2010–2030. Conti RM. The economic value of new treatments for depression [Doctoral dissertation]. Cambridge, MA: Harvard University; 2006. Fortinguerra F, Tafuri G, Trotta F, et al. Using GRADE methodology to assess innovation of new medicinal products in Italy. Br J Clin Pharmacol. 2020;86(1):93–105. Djupesland PG, Messina JC, Mahmoud RA. Breath powered nasal delivery: a new route to rapid headache relief. Headache. 2013;53(S2):72–84. Rezvani M, Hesari J, Peighambardoust SH, et al. Development and characterization of nanostructured pharmacosomal mesophases: an innovative delivery system for bioactive peptides. Adv Pharm Bull. 2018;8(4):609–615. Graziottin A. Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review. Patient Prefer Adherence. 2008;2:357–367. Stephanie W, Hill C, Ricks ML, et al. The scope and impact of mobile health clinics in the United States: a literature review. Int J Equity Health. 2017;16(1):1–12. Balducci AG, Magosso E, Colombo G, et al. From tablets to pharmaceutical nanotechnologies: innovation in drug delivery strategies for the administration of antimalarial drugs. J Drug Delivery Sci Technol. 2016;32:167–173. Moreira M, Sarraguça M. How can oral paediatric formulations be improved? A challenge for the XXI century. Int J Pharm. 2020;590:119905. Chagpar AB. Innovation in surgery: from imagination to implementation. Am J Surg. 2011;202(6):641–645. Biddiscombe MF, Usmani OS. Is there room for further innovation in inhaled therapy for airways disease? Breathe. 2018;14(3):216–224. Charlton V, Rid A. Innovation as a value in healthcare priority-setting: the UK experience. Soc Justice Res. 2019;32(2):208–238. Nicod E, Brigham KB, Durand-Zaleski I, et al. Dealing with uncertainty and accounting for social value judgments in assessments of orphan drugs: evidence from four European countries. Value Health. 2017;20(7):919–926. Roubou I, Alexopoulou DK. The various shapes of innovation. Forum Clin Oncol. 2015;6(4):12–22. Belloso WH. On innovation. Ther Innov Regul Sci. 2020;54(5):1068–1075. Monia M. Value of innovation for hematologic malignancies. J Med Econ. 2016;19(5):487–489. Toskin I, Blondeel K, Peeling RW, et al. Advancing point of care diagnostics for the control and prevention of STIs: the way forward. Sex Transm Infect. 2017;93(S4):S81–S88.